Radiotherapy, Conformal

Displaying 1 - 3 of 3CSV
Konski, A., Deshmukh, S., Klopp, A. H., Yeung, A. R., Westin, S. N., Thompson, J. S., Doncals, D. E., Cantuaria, G. H. C., D’Souza, D. P., Chang, A., Kundapur, V., Mohan, D. S., Haas, M. L., Kim, Y. B., Ferguson, C. L., Pugh, S. L., Kachnic, L. A., & Bruner, D. W. (2023). Quality-adjusted survival in women with gynecologic malignancies receiving IMRT after surgery: A Ppatient Rreported Ooutcome study of NRG oncology’s RTOG 1203. Gynecologic Oncology, 175, 176–181. https://doi.org/10.1016/j.ygyno.2023.05.074
Publication Date
Garrett, M. D., Li, F., Lemus, O. D., Lavrova, E., Savacool, M., Price, M. J., Kachnic, L. A., Horowitz, D. P., & Chin, C. (2023). Impact of Adapted Radiotherapy Schedules on Bowel Sparing in Node-Positive Cervical Cancer. Practical Radiation Oncology, 13(2), e184–e191. https://doi.org/10.1016/j.prro.2022.11.012
Publication Date
Kharofa, J. R., Yothers, G., Kachnic, L. A., Ajani, J., Meyer, J. E., Augspurger, M. E., Okawara, G. S., Garg, M. K., Schefter, T. E., Swanson, T. A., Doncals, D. E., Kim, H., Zaki, B. I., Narayan, S., Lee, R. J., Mamon, H. J., Schwartz, M. A., Moughan, J., & Crane, C. H. (2022). Use of the Toxicity Index in Evaluating Adverse Events in Anal Cancer Trials. American Journal of Clinical Oncology, 45(12), 534–536. https://doi.org/10.1097/coc.0000000000000955
Publication Date